人體生長荷爾蒙市場規模、佔有率、成長分析、按產品、按應用、按分銷管道、按地區 - 產業預測，2024-2031 年

Human Growth Hormone Market Size, Share, Growth Analysis, By Product, By Application (Growth Hormone Deficiency, Turner Syndrome), By Distribution Channel, By Region - Industry Forecast 2024-2031

出版日期: 2024年09月28日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2022年人體生長荷爾蒙的全球市場規模為55億美元，從2023年的63.2億美元成長到2031年的160.3億美元，在預測期間（2024-2031年）預計將以複合年成長率成長。 %。

人體生長荷爾蒙（HGH）市場旨在解決生長激素缺乏症和相關疾病，如透納氏症、普瑞德威利症候群和慢性腎臟病。這些疾病的日益普及以及患者和醫療保健提供者對 HGH 治療益處的認知不斷提高，推動了市場的發展。然而，治療成本上漲、嚴格監管以及處方箋管理需求等挑戰正在阻礙市場成長。儘管存在這些挑戰，HGH 市場仍提供了機遇，包括精準醫學和個人化治療、再生醫學、荷爾蒙補充療法的開拓、對老齡化相關疾病的持續研究以及可提高治療效果的藥物輸送技術的進步。總體而言，HGH 市場在生長激素相關疾病的管理中發揮重要作用，並得到生物技術進步和意識不斷提高的支持。

市場概況
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲國家地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 其他亞太地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲 (MEA)
- 海灣合作理事會國家
- 南非
- 其他中東/非洲地區

競爭格局

前5名企業對比
主要企業市場定位（2023年）
主要市場參與者所採取的策略
近期市集活動
主要企業市場佔有率（2023年）

主要企業簡介

Novo Nordisk A/S
Pfizer, Inc
Eli Lilly and Company
Sandoz International GmbH（Novartis AG）
Merck KGaA
Genentech, Inc（Roche）
Ferring Pharmaceuticals
Teva Pharmaceutical Industries, Ltd
Ipsen
GeneScience Pharmaceuticals
LG Chem
Anhui Anke Biotechnology Group
Biopartners
Endo International
Versartis
Opko Health
Rani Therapeutics
Somatopac
Hua'an Biological
Hangzhou Just Biotech
Shenzhen Hybio Pharmaceutical

簡介目錄

Product Code: SQMIG35I2308

Global Human Growth Hormone Market size was valued at USD 5.5 billion in 2022 and is poised to grow from USD 6.32 billion in 2023 to USD 16.03 billion by 2031, growing at a CAGR of 12.34% during the forecast period (2024-2031).

The human growth hormone (HGH) market aims to address growth hormone deficiencies and related disorders, including conditions like Turner syndrome, Prader-Willi syndrome, and chronic kidney disease. The market is driven by the increasing prevalence of these disorders and growing awareness among patients and healthcare providers about the benefits of HGH therapy. However, challenges such as the high cost of therapy, stringent regulations, and the need for prescription-based administration hinder market growth. Despite these challenges, opportunities abound in the HGH market, including the development of precision medicine and personalized treatments, ongoing research into regenerative medicine, hormone replacement therapy, and age-related disorders, and advancements in drug delivery technologies that enhance treatment outcomes. Overall, the HGH market plays a crucial role in managing growth hormone-related disorders and is supported by advancements in biotechnology and increasing awareness.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Human Growth Hormone market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Human Growth Hormone Market Segmental Analysis

Global Human Growth Hormone Market is segmented by Product, Application, Distribution Channel and region. Based on Product, the market is segmented into Long Acting, Others. Based on Application, the market is segmented into Growth Hormone (GH) Deficiency (Adult GH Deficiency, Pediatric GH Deficiency), Turner Syndrome, Idiopathic Short Stature, Prader-Willi Syndrome, Small For Gestational Age, Others. Based on Distribution Channel, the market is segmented into Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Specialty Pharmacy. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Drivers of the Global Human Growth Hormone Market

The rising prevalence of growth hormone-related disorders, including growth hormone deficiency and genetic conditions, is fueling the demand for HGH therapy. In 2022, heightened awareness and improved diagnostic capabilities led to more patients seeking treatment. According to the European Society for Paediatric Endocrinology (ESPE), there was a notable increase in the incidence of growth hormone deficiency among children in Europe during that year. This surge in cases has driven a greater need for HGH therapy to address growth hormone-related issues in affected children.

Restraints in the Global Human Growth Hormone Market

The high costs associated with HGH treatment can create significant barriers to access for some patients and healthcare systems. A 2022 study published in a medical journal underscored the financial strain that both patients and healthcare providers experience due to the steep price of HGH therapy. This highlighted the urgent need for more cost-effective solutions and potential pricing reforms to improve accessibility to HGH treatment.

Market Trends of the Global Human Growth Hormone Market

Physicians and researchers are increasingly prioritizing personalized HGH therapy, considering individual patient characteristics such as genetic factors and specific medical conditions. In 2022, a clinical trial was launched to assess the effectiveness of personalized dosing regimens for HGH therapy in children with growth hormone deficiency. The goal of this trial was to determine the advantages of tailored treatment approaches in enhancing growth outcomes.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Key Success Factor
Degree of Competition
Top Investment Pockets
Ecosystem of the Market
Pricing Analysis
PESTEL Analysis

Human Growth Hormone Market, By Product

Market Overview
Long Acting
Others

Human Growth Hormone Market, By Application

Market Overview
Growth Hormone (GH) Deficiency
- Adult GH Deficiency
- Pediatric GH Deficiency
Turner Syndrome
Idiopathic Short Stature
Prader-Willi Syndrome
Small For Gestational Age
Other

Human Growth Hormone Market, By Distribution Channel

Market Overview
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Specialty Pharmacy

Human Growth Hormone Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2023

Key Company Profiles

Novo Nordisk A/S
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pfizer, Inc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Eli Lilly and Company
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sandoz International GmbH (Novartis AG)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck KGaA
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Genentech, Inc (Roche)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ferring Pharmaceuticals
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Teva Pharmaceutical Industries, Ltd
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ipsen
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GeneScience Pharmaceuticals
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
LG Chem
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Anhui Anke Biotechnology Group
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biopartners
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Endo International
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Versartis
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Opko Health
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Rani Therapeutics
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Somatopac
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hua'an Biological
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hangzhou Just Biotech
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Shenzhen Hybio Pharmaceutical
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments